IBEX Technologies Inc (IBT.V)

IBT.V on TSX Venture Exchange

0.05CAD
16 Apr 2015
Change (% chg)

-- (--)
Prev Close
$0.05
Open
--
Day's High
--
Day's Low
--
Volume
423
Avg. Vol
11,121
52-wk High
$0.10
52-wk Low
$0.05

IBT.V

Chart for IBT.V

About

IBEX Technologies Inc is a Canada-based Company that manufactures and markets enzymes for biomedical use. The company produces a family of high purity recombinant glycosaminoglycan (GAG) lyases, namely Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC and Chondroitinase B. It also produces a series of arthritis... (more)
No analyst recommendations are available for IBT.V.

Overall

Beta: 0.81
Market Cap(Mil.): $1.36
Shares Outstanding(Mil.): 24.70
Dividend: --
Yield (%): --

Financials

  IBT.V Industry Sector
P/E (TTM): -- 155.83 41.17
EPS (TTM): -0.02 -- --
ROI: -9.68 -1.02 16.08
ROE: -12.37 -2.93 16.92
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks